Figure 1From: Sympathetic hyperactivity influences chemosensor function in patients with end-stage renal disease Hyperoxic chemoreflex sensitivity (CHRS) is impaired in end-stage renal disease (ESRD) patients (n = 10) as compared with controls (n = 10). Values are means ± SEM.Back to article page